Image of David Ph.D.

David Ph.D.

Chair - Science, Math and Engineering depts; STEAM (Science, Technology, Engineering, Art and Math)

Chief Operating Officer at Multimeric Biotherapeutics, Inc.

Greater San Diego Area

Section title

David Ph.D.'s Email Addresses & Phone Numbers

David Ph.D.'s Work Experience

Wasatch Academy

Chair - Science, Math and Engineering depts; STEAM (Science, Technology, Engineering, Art and Math)

2010 to Present

Multimeric Biotherapeutics, Inc.

Chief Operating Officer

October 2007 to Present

Wasatch Academy

Teacher, Director and Coach

2010 to 2015

David Ph.D.'s Education

University of Colorado at Boulder

Assistant Professor Integrative Physiology Undergraduate Graduate and Postdoctoral Fellow

1992 to 1998

University of California, San Diego - School of Medicine

Postdoctoral Fellow Molecular Cardiology

1989 to 1992

University of California, Berkeley

BA MS PhD Pre-Med; Physiology; Biochemistry

1981 to 1989

David Ph.D.'s Professional Skills Radar Chart

Based on our findings, David Ph.D. is ...


What's on David Ph.D.'s mind?

Based on our findings, David Ph.D. is ...

52% Left Brained
48% Right Brained

David Ph.D.'s Estimated Salary Range

About David Ph.D.'s Current Company

Wasatch Academy

Wasatch Academy in an international (40 countries, 28 states) college preparatory boarding school in Mount Pleasant, Utah. We specialize in Individualized- and Project-Based learning (PBL), Outdoor/Experiential Education, and whole-student oriented academic and social development through multiple advisee/advisor, cross-curricular, and integrative programs such as STEAM, the Studio, Physical, and Performing Arts. Come visit and see for yourself the...

Frequently Asked Questions about David Ph.D.

What company does David Ph.D. work for?

David Ph.D. works for Wasatch Academy

What is David Ph.D.'s role at Wasatch Academy?

David Ph.D. is Chair - Science, Math and Engineering depts; STEAM (Science, Technology, Engineering, Art and Math)

What is David Ph.D.'s personal email address?

David Ph.D.'s personal email address is d****[email protected]

What is David Ph.D.'s business email address?

David Ph.D.'s business email address is d*****

What is David Ph.D.'s Phone Number?

David Ph.D.'s phone (**) *** *** 339

What industry does David Ph.D. work in?

David Ph.D. works in the Biotechnology industry.

About David Ph.D.

📖 Summary

Recognized executive level scientific and management experience in drug development and R&D environments in the biotechnology, pharmaceutical, and industrial enzyme industries. Extensive experience in a variety of animal models and cell- and molecular biology-based R&D strategies with business and commercial development experience. Areas of expertise: • Research Operations • Pre-clinical Product Development • Protein, Peptide and Gene Therapeutics • Protein- and DNA-based Vaccine and Diagnostics Development • Biologics Discovery and Development • Strategic Alliances and Business Development • Grants and Contracts: Successful SBIR and STTR awards in multiple start-up biotechnology companies from multiple agencies (NIH, DoD, DARPA, NMRC, DoE). • Life Sciences Portfolio Management • Experienced and effective manager of Ph.D. level scientists and research associates. • Strong analytical, communication, project management and budgeting skills. Specialties: Research Ops, Preclinical Dev • Biologics and Technology Development • Strategic alliances, collaborative R&D projects • Contracts and grants Business Development • Strategic business planning/development • Technology evaluation, due diligence • Licensing • Alliances and partnerships IP Capture & Expansion, Asset Management • New inventions: patents, trademarks • Identification of IP opps, freedom to operate • Strategic portfolio building • Scientific and IP liaisonChair - Science, Math and Engineering depts; STEAM (Science, Technology, Engineering, Art and Math) @ Wasatch Academy in an international (40 countries, 28 states) college preparatory boarding school in Mount Pleasant, Utah. We specialize in Individualized- and Project-Based learning (PBL), Outdoor/Experiential Education, and whole-student oriented academic and social development through multiple advisee/advisor, cross-curricular, and integrative programs such as STEAM, the Studio, Physical, and Performing Arts. Come visit and see for yourself the melding of academic vision, whole-campus participation, and community service in action! From 2010 to Present (5 years) Chief Operating Officer @ I am COO and co-founder of MultimericBio with my partners, Richard S. Kornbluth, MD, PhD - President and CSO, and Marc Hertz, PhD - Chairman of the Board, based in La Jolla, CA. We are a young biotechnology company with worldwide rights to licensed patents covering all of the TNF SuperFamily ligands (CD40 Ligand is our lead product - the multimeric (many trimer) form is called Ultra-CD40L) from UCSD that enables a powerful platform technology for clinical development of cancer immunotherapies and robust adjuvants for infectious disease vaccines. We have multiple active USG grants and contracts, extensive partnerships in biotech and pharma, and are actively seeking private funding from VC and private investor sources. From October 2007 to Present (8 years 3 months) Teacher, Director and Coach @ From 2010 to 2015 (5 years) Senior Director - R&D and Research Operations @ Research Operations; Preclinical Development; IND and NDA submissions; Discovery Research and R&D program tracking and timetable management; RA/QA and Regulatory Affairs/Operations liaison; Budget forecasting and tracking; Grants and Contracts (USG, public, and private agencies) opportunity identification, proposal writing and submissions; Management of External Collaborations: identifying, initiating, timeline and milestone tracking and reporting of collaborative activities (Academic, Industry, Contract Research: CDA, MTA, MRA, SOW, and MSA agreements, R&D planning, project management); identifying, initiating and managing external R&D programs at CROs (contract research organizations: non-clinical, toxicology); patent capture and extension; strategic alliances and business development; scientific liaison across departmental lines in a matrix-based R&D organization. From December 2008 to May 2010 (1 year 6 months) Principal @ We provide strategic consulting to the biotechnology and pharmaceutical industry, including: Preclinical pharmacology and toxicology planning; CRO engagement and due diligence; Business development and scientific planning; Angel, VC and corporate venture fundraising; Business plan development; In- and out-licensing of technologies/IP; Due diligence including legal/IP/freedom to operate; Product development strategies; Writing grants and contracts submitted to public and private funding agencies for non-dilutive financing; and technical consultation for private biotechnology companies. Recent CLIENTS include: EpiVax, Inc., Immunex/Amgen, Genentech/Roche, Merck, Inc., Schering, AG, Multimeric Biotherapeutics, Inc., Cardium Therapeutics, Inc. Recent PROJECTS include: cancer immunotherapeutics, protein- and nucleotide-based therapeutic product development; immunogenicity screening; preventative and therapeutic vaccines and adjuvant development; antigen discovery; and preclinical pharmacology and toxicology program development. From February 2008 to December 2008 (11 months) Sr. VP - R&D @ CODA Genomics is a synthetic biology-based biotechnology company spun out of UC-Irvine Depts of Microbiology and Molecular Genetics (School of Medicine), and Computer Sciences. I was responsible for creating and developing applications for CODA’s gene design and protein optimization products and technologies pipeline, developing and managing the intellectual property portfolio, and creating and maintaining strategic business and academic collaborations for grants, alliances, and strategic relationships. I worked closely with CODA’s Business and Market Development, Operations, and Sales and Marketing teams to conceive, propose, execute, and manage corporate funded partnerships related to CODA’s technologies and their applications. I managed all interactions with CODA’s Scientific Advisory Board, and worked closely with the company founders, CODA’s Board of Directors, and patent and corporate attorneys to develop new applications of the CODA’s technologies, including engineered enzymes for biofuel synthesis. Using these grant-backed enzymes CODA has now become Verdezyne, Inc., focusing on renewable biofuels. From March 2006 to January 2008 (1 year 11 months) Advisor and Mentor (volunteer) @ Resounding Joy is a public-benefit, California non-profit 501c3 corporation, dedicated to providing a supportive and healing music environment to adults and children who are homebound or have special needs. Resounding Joy accepts referrals from individuals and community-based organizations who want to offer recreational music-making programs hospital-bound children through rest/retirement home-bound older adults. Resounding Joy trains volunteer Joy Givers to bring words and sounds of hope, encouragement and appreciation for the joy and consolation brought by music. It has been shown in countless small and large group venues that Music is Therapy. From February 2004 to March 2007 (3 years 2 months) Vice President - R&D @ • Developed Vaccinomics (TM/SM), a high throughput antigen discovery platform for development of protective and therapeutic vaccines and diagnostics. • Identified and executed on new funding opportunities including VC, new business alliances and partnerships, technology licensing and therapeutic applications of platform technologies. • Spearheaded and wrote successful SBIR and STTR grants and contract applications. • Business Development: identified and negotiated strategic alliances and partnerships with vaccine and diagnostic companies, US government, and non-profit organizations. • Identified and evaluated novel gene- and protein-based technologies for the product pipeline through licensing deals with Technology Transfer Offices at academic and research institutions. • Designed and oversaw the development of new products. • Wrote new patent applications for novel products invented in-house. • Created and directed collaborations and partnerships with biotechnology, vaccine and diagnostic companies, academic and institutional collaborations, and scientific consultants/SAB. From January 2003 to March 2006 (3 years 3 months) Director of Research and Technology @ • Directed all preclinical activities of the R&D group, including in vivo and in vitro work in a variety of animal models and cell-based and viral vector systems, and development of new catheter-based and cardiovascular imaging systems. • Managed the work of 25 scientists: cell and molecular biology, biochemistry, rodent and large animal physiology/pharmacology, and process development. • Created, implemented, and directed internal research and development programs and collaborative R&D projects. • Directed and coordinated internal interactions between R&D, program management, quality assurance, regulatory affairs, legal counsel (patents, licensing, IP), process development and manufacturing (GLP, GMP, QA/QC), pre-clinical and clinical development, HR, financial planning and budgets. • Directed and reported interactions between Collateral and industrial alliances, academia, scientific consultants, CROs and CSOs, the FDA (Center for Biologics and Evaluation Research – CBER), and the Recombinant DNA Advisory Committee (RAC) at the NIH. • Leadership during evaluation and prioritization of programs and projects during acquisition/transition phases of Collateral with Schering, AG-Berlex Biosciences. From July 1998 to December 2002 (4 years 6 months) Key Word Search @ Keywords Key Word Search (Privately Held; Biotechnology industry) January 1976 — January 1977 (1 year 1 month) Cardiovascular, CV, angiogenesis, peripheral vascular disease, PVD, catheter, Diabetes, T1DM, T2DM, insulin, hyaluronidase, rHuPH20, streptozotocin, protein biologics, DNA, RNA, RNAi, miRNA, vaccines, diagnostics, infectious disease, antibody, Ab, MAb, mAb, antigen, Ag, receptor, ligand, biotherapeutics, adjuvants, grants, contracts, USG, ADA, DOD, DOE, NIH, SBIR, STTR, NMRC, CDC, WHO, strategic stockpiling, co-development, research, R&D, development, business development, BD, Alliance Management, cGMP, strategic alliances, Professional Relations, Advocacy Development, program management, project management, Vice President, VP, Senior Vice President, SVP, Senior Director, Director, gene therapy, viral, vectors, cancer, immunology, melanoma, skin cancer, lymphoma, NSCLC, T-Cell, lung cancer, non-small cell, ovarian, breast cancer, IND, NDA, DEA, infusion products, new product development, vendor management, agency management, executive management, senior management, providers, advocacy, society, SC, subcutaneous, IV, intravenous, IC, intracoronary, ID, intradermal, biosimilars, preclinical, pre-clinical, non clinical, non-clinical, nonclinical, enabling, platform technologies, consultant, consulting, SAB, mentor. From January 1998 to December 1998 (1 year) Assistant Professor @ Tenure-track with research (40%), teaching (40%), and service (20%): • Research: successful and consistent intramural & extramural grant funding for basic and applied research and student training fellowships (American Heart Assn, American Fed for Aging Res, Howard Hughes Biomedical Research Foundation (UROP); fostered academic and industry collaborations. • Teaching: undergraduate (Physiology lecture/labs and seminars) and graduate (Biochemistry and Molecular Endocrinology lecture/labs and seminars). • Service: national, state, community, and university-wide committees. Winner: Teaching Excellence Award, CU-Boulder Student Organization for Alumni Relations. Award for tenure track faculty (~1,100 eligible) for the 30-75 undergraduate student class size. April, 1998 Biomedical Research Award - 1993 American Federation of Aging Research (AFAR) Finalist: Faculty Excellence in Research, Scholarly, and Creative Work Award. Boulder Faculty Assembly, CU-Boulder. May 1995. From August 1992 to July 1998 (6 years) Assistant Professor, Integrative Physiology, Undergraduate, Graduate and Postdoctoral Fellow @ University of Colorado at Boulder From 1992 to 1998 Postdoctoral Fellow, Molecular Cardiology @ University of California, San Diego - School of Medicine From 1989 to 1992 BA, MS, PhD, Pre-Med; Physiology; Biochemistry @ University of California, Berkeley From 1981 to 1989 Albuquerque Academy - Independent High School David Ph.D. is skilled in: Patents, Technology Evaluation, Biotechnology, Lifesciences, Drug Development, Drug Discovery, Start-ups, Clinical Development, Immunology, Cell, Protein Chemistry, Technology Transfer, Biopharmaceuticals, Infectious Diseases, Molecular Biology

David Ph.D.’s Personal Email Address, Business Email, and Phone Number

are curated by ContactOut on this page.

10x your recruitment & sales conversations

Contact over 200M professionals
instantly by email or phone. Reveal
personal & work email addresses, as
well as phone numbers accurately with
our ContactOut Chrome extension.

In a nutshell

David Ph.D.'s Personality Type

Extraversion (E), Sensing (S), Feeling (F), Judging (J)

Average Tenure

3 year(s), 8 month(s)

David Ph.D.'s Willingness to Change Jobs



Open to opportunity?

There's 88% chance that David Ph.D. is seeking for new opportunities

David Ph.D.'s Social Media Links

Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 400K users from

76% of Fortune 500 companies

Microsoft Nestle PWC JP Morgan Merck Rackspace WarnerMedia Randstad Yelp Google

The most accurate data ever

CCPA Compliant
GDPA Aligned
150M Personal Emails
300M Work Emails
50M Direct Dials
200M Professional Profiles
30M Company Profiles

Hire Anyone, Anywhere
with ContactOut today

Making remote or global hires? We can help.

  • 50 contacts/month
  • Works on standard LinkedIn only
  • Work emails, personal emails, mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free